Jessica Meng
Net worth: 4 M $ as of 2026-05-30
Net worth: 4 M $ as of 2026-05-30
Jessica Meng is Chief Commercial Officer at CareDx, Inc. since 2024.
Former roles include Vice President-Marketing at Veracyte, Inc. from 2018 to 2020 and Chief Commercial Officer at Delfi Diagnostics, Inc. Education includes an undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAREDX, INC. 0.33% | 2026-03-31 | 169,392 ( 0.33% ) | 4 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CAREDX, INC. | Corporate Officer/Principal | 2024-09-11 |
| Companies | Position | End |
|---|---|---|
| VERACYTE, INC. | Sales & Marketing | 2020-04-30 |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Health Services |
Select your edition
All financial news and data tailored to specific country editions